Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors' Dealings notification transmitted by DGAP – a service of EQS Group AG. The person with duty of notification is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Details of the person subject to the disclosure requirement Last name: Retzlaff First name: Eliza Marie Relationship to a person performing managerial responsibilities: Dependent child Details of the person performing managerial responsibilities Position: Member of a managing body Information about the transaction with duty of notification Description of the financial instrument: STADA Arzneimittel AG, Registered shares with restricted transferability and without par value ISIN/WKN of the financial instrument: DE0007251803 Type of transaction: Sale Date: 24.06.2016 Price: 44.207 Currency: EUR No. of items: 3000 Total amount traded: 132621.00 Place: Xetra Information about the company with duty of publication Issuer: STADA Arzneimittel AG Stadastraße 2-18 61118 Bad Vilbel Germany ISIN: DE0007251803 WKN: 725180 End of Directors' Dealings Notification (c) DGAP 30.06.2016 DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de ID 26083
DGAP-DD: STADA Arzneimittel AG english
| Source: EQS Group AG